XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Net income $ 9,177 $ 10,286 $ 24,926 $ 27,642  
Adjustments to reconcile net income to net cash from operating activities          
Provision for credit losses 2,309 1,513 5,922 3,989  
Depreciation, amortization and accretion     9,444 7,948  
Compensation expense related to stock options and restricted stock awards     1,621 1,248  
Earnings on cash surrender value of BOLI     (773) (734)  
Gain on sale of loans held for sale     (6,111) (6,824)  
Gain on sale of MSRs 0 (141) 0 (8,356)  
Loss on sale of investment securities, net 0 (11) 0 7,836  
Change in fair value on portfolio loans measured under the fair value option     (469) (448)  
Origination of loans held for sale     (354,231) (426,672)  
Proceeds from sale of loans held for sale     379,654 430,421  
Gain on purchase of tax credits     (660) (2,262)  
Purchase of tax credits     (7,587) (26,007)  
(Recovery) impairment of MSRs (6) 506 23 545  
Changes in operating assets and liabilities          
Accrued interest receivable     (1,241) (9)  
Other assets     8,146 3,758  
Other liabilities     1,294 (2,781)  
Net cash from operating activities     59,958 9,294  
CASH FLOWS USED BY INVESTING ACTIVITIES          
Proceeds from sale of investment securities 0 3,448 0 101,907  
Maturities, prepayments, and calls     35,616 13,403  
Purchases     (61,724) (47,729)  
Purchases     (25,985) 0  
Maturities of certificates of deposit at other financial institutions     1,727 14,874  
Purchase of certificates of deposit at other financial institutions     0 (2,708)  
Portfolio loan originations and principal collections, net     (132,008) (37,425)  
Proceeds from sale of MSRs     0 16,311  
Proceeds from sale of portfolio loans     2,309 0  
Purchase of portfolio loans     (3,956) (50,099)  
Purchase of premises and equipment     (4,665) (1,253)  
Proceeds from bank owned life insurance death benefits     771 0  
Change in FHLB stock, net     7,646 (7,390)  
Maturities, prepayments, and calls     3,000 0  
Net cash used by investing activities     (177,269) (109)  
CASH FLOWS FROM (USED BY) FINANCING ACTIVITIES          
Net increase (decrease) in deposits     347,047 (95,097)  
Proceeds from borrowings     626,436 707,768  
Repayments of borrowings     (804,937) (637,708)  
Dividends paid on common stock     (8,157) (6,153)  
Disbursements from stock options exercised, net     (20) (1,284)  
Issuance of common stock - employee stock purchase plan     937 832  
Common stock repurchased     (13,886) (2,508)  
Net cash from (used by) financing activities     146,956 (34,536)  
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS     29,645 (25,351)  
CASH AND CASH EQUIVALENTS, beginning of period     31,635 65,691 $ 65,691
CASH AND CASH EQUIVALENTS, end of period $ 61,280 $ 40,340 61,280 40,340 $ 31,635
Common stock repurchased for employee/director taxes paid on restricted stock awards     (464) (386)  
SUPPLEMENTARY DISCLOSURES OF CASH FLOW INFORMATION          
Interest on deposits and borrowings     47,460 47,071  
Income taxes     89 2,435  
SUPPLEMENTARY DISCLOSURES OF NONCASH OPERATING, INVESTING AND FINANCING ACTIVITIES          
Change in fair value on available-for-sale investment securities     5,640 11,689  
Change in fair value on fair value and cash flow hedges     (5,893) (5,288)  
Retention in gross MSRs from loan sales     1,242 1,891  
ROU assets in exchange for lease liabilities     $ 3,013 $ 0